SCHEMBL30840393

SCHEMBL30840393

C=C(C(=O)OC(C)(C)C)[Sn](CCCC)(CCCC)CCCC

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.33
CTSK P43235 2/20 0.31
CTSS P25774 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL537242 0.79 ALDH1A1 (0.38) TSHR
SCHEMBL6602326 0.78 ALDH1A1 (0.41) TSHR
SCHEMBL6012107 0.72 AKR1B1 (0.36) TSHR
SCHEMBL21981517 0.72 CES1 (0.39) TSHRCTSK
SCHEMBL9848119 0.71 TDP1 (0.35) TSHR
SCHEMBL787672 0.70 CES2 (0.41) TSHR
SCHEMBL28326775 0.69 CES2 (0.43) TSHR
SCHEMBL12948689 0.69 CES2 (0.43) TSHR
SCHEMBL28360214 0.69 CES2 (0.43) TSHR
SCHEMBL28126297 0.69 CES2 (0.43) TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4583972-A1 MACROCYCLIC COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THEREOF Sionna Therapeutics Inc. (US) 2025-07-16 EP disclosed
WO-2024054840-A1 MACROCYCLIC COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THEREOF SIONNA THERAPEUTICS (US) 2024-03-14 WO disclosed